Olmesartan Medoxomil is an angiotensin II receptor antagonist which has been used for the treatment of high blood pressure.It was developed by Sankyo in 1995 and it is an ester prodrug that is completely and rapidly hydrolyzed to the active acid form, olmesartan (RNH-6270).
Olmesartan Medoxomil is an angiotensin II receptor antagonist. This angiotensin II receptor antagonist has been used for the treatment of high blood pressure.It was developed by Sankyo in 1995 and it is an ester prodrug. This ester prodrug is completely and rapidly hydrolyzed to the active acid form. The active acid form is olmesartan (RNH). RNH is 6270.